PRTA (PRTA) Stock Price & Analysis
PRTA (PRTA) rose 0.00% to USD 8.75 as of July 25, 2026 at 03:42 UTC, according to Nexqual real-time market data.
PRTA last closed at USD 8.75; the session ranged USD 8.36–8.83 on volume of 567,503 shares. Market capitalization is —, with a 52-week range of USD 6.58–11.8 (NMS). Source: Nexqual, July 25, 2026 at 03:42 UTC.
Key Statistics (as of July 25, 2026 at 03:42 UTC)
| Price | USD 8.75 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 8.75 |
| Open | USD 8.75 |
| Day Range | USD 8.36 – 8.83 |
| 52-Week Range | USD 6.58 – 11.8 |
| Volume | 567,503 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (PRTA)
Nexqual's technical model rates PRTA "STRONG SELL" based on 0 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 03:42 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 46.81 (neutral) |
| vs SMA50 | Below (USD 9.17) |
| MACD | -0.2 (negative) |
From PRTA's Latest SEC 10-K Filing (filed 2026-02-27)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PTCT | PTC Therapeutics, Inc. | USD 76.82 | ▼ 2.02% |
| RARE | Ultragenyx Pharmaceutical Inc. | USD 26.9 | ▼ 2.69% |
| AGIO | Agios Pharmaceuticals, Inc. | USD 36.36 | ▲ 0.86% |
| ENTA | Enanta Pharmaceuticals, Inc. | USD 12.78 | ▼ 2.14% |
| XNCR | Xencor, Inc. | USD 19.44 | ▼ 0.36% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:42 UTC. This page is informational and not investment advice.